Alice Tarantal, PhD: Fetal models of human disease; fetal therapy with a focus on cell and gene transfer; gene therapy; fetal growth regulation and restriction; role of the insulin-like growth factor (IGF) system; ultrasonography; nonhuman primate models; hematopoietic ontogeny; reproductive biology. Dr. Tarantal’s research program primarily focuses on fetal diseases and corrective therapies, with a focus on cell and gene-based therapies. The activities in the Tarantal laboratory cover the following areas of nonhuman primate research: (1) gene therapy, (2) stem cells/cell-based therapies, (3) fetal models of human congenital and acquired diseases, (4) maternal:fetal microchimerism, and (5) imaging applications. Dr. Tarantal has been at the forefront in the use of monkey models to parallel human congenital illnesses and novel treatment strategies, and has been a leader in the use of ultrasound imaging for these applications. Dr. Tarantal has NIH-funded projects that focus on gene therapy approaches for heart, lung, and blood diseases, and for studies with hematopoietic, mesenchymal, and embryonic stem cells.